A new vaccine against Covid-19 has been successfully tested in animal experiments at the University of Basel: the vaccine, which is based on modified coronaviruses, should be able to be administered through the nose or mouth.
According to the university, the viruses adapted for the vaccine could enter cells and thus trigger a desired immune system. However, they cannot multiply in the body.
protection for unvaccinated people
Researchers at the Department of Biomedicine at the University of Basel tested the vaccine with nasal drops on hamsters. All animals were protected from disease, it said. In addition, the vaccination prevented non-vaccinated animals from becoming infected.
Quickly adaptable
As an additional advantage, the university mentions that the vaccine can be quickly adapted to new variants and other viruses. It is also suitable for people who shy away from the new mRNA vaccines or injections.
patent filed
The university applied for a patent on the vaccine concept, which was developed together with the Basel-based company RocketVax. Human clinical trials are expected to follow shortly. For the time being, the results will be submitted to a professional journal for independent assessment. They are also accessible on a preprint server.
Source: Krone
I am an experienced and passionate journalist with a strong track record in news website reporting. I specialize in technology coverage, breaking stories on the latest developments and trends from around the world. Working for Today Times Live has given me the opportunity to write thought-provoking pieces that have caught the attention of many readers.
